Adma Biologics | ADMA - 营业利润

金融业

USD 11.37

USD 684.21M

现金及等价物

USD 136.02M

USD 38.12M

USD 528.2M

USD 75.76M

USD 203.84M

USD 53.66M

USD 55.44M

624

EPS每股收益

USD 0.16

股本和储备

USD 408.21M

USD 86.28M

债务利息支出

USD 3.42M

USD 1.24M

USD 192.84M

USD 2.61B

USD 37.82M

USD 71.95M

USD 52.45M

普通股股本

USD 225.36M

12.28

USD 50.24M

USD 124.4M

销售和管理费用

USD 26.74M

USD 239.31M

贸易债权人

USD 31.72M

应收帐款人

USD 138.23M

	营业利润	更改		日
Adma Biologics	USD 52.44M		2.15M	2026-06
Alnylam Pharmaceuticals	USD 179.66M		67.06M	2026-09
BioCryst Pharmaceuticals	USD 98.46M		161.92M	2026-06
Minerva Neurosciences	USD -21.85M		17.48M	2024-12
Novavax	USD 20.94M		100.32M	2025-12
Omeros	USD -35.41M		23.75M	2024-09
Takeda	JPY 205.32B		3.9B	2026-09